Health

Cheaper biosimilar medicines to be allowed under new law

State expenditure on pharmaceuticals has doubled in the last ten years from €1.3 billion in 2012 to €2.6 billion in 2022 and now represents one of the largest components of overall health expenditure

A biological medicine is derived from living organisms unlike more most medicines which are made from chemical synthesis